Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.110
+0.100 (2.49%)
At close: Mar 9, 2026, 4:00 PM EDT
4.180
+0.070 (1.70%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Prime Medicine Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 728 | 614 | 373 | 817 | 1,609 | - | |
| Market Cap Growth | 82.23% | 64.88% | -54.41% | -49.22% | - | - | |
| Enterprise Value | 667 | 519 | 238 | 669 | 1,890 | - | |
| Last Close Price | 4.11 | 3.47 | 2.92 | 8.86 | 18.58 | - | |
| PS Ratio | 157.12 | 132.63 | 124.90 | - | - | - | |
| PB Ratio | 6.02 | 5.08 | 2.43 | 6.14 | 5.09 | - | |
| P/TBV Ratio | 6.02 | 5.08 | 2.43 | 6.14 | 5.09 | - | |
| EV/Sales Ratio | 143.90 | 112.08 | 79.89 | - | - | - | |
| Debt / Equity Ratio | 0.96 | 0.96 | 0.27 | 0.10 | 0.09 | 0.04 | |
| Net Debt / Equity Ratio | -0.51 | -0.51 | -0.98 | -0.81 | -0.84 | -1.08 | |
| Net Debt / EBITDA Ratio | 0.31 | 0.31 | 0.76 | 0.58 | 2.32 | 3.09 | |
| Net Debt / FCF Ratio | 0.37 | 0.37 | 1.15 | 0.62 | 1.79 | 6.78 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | - | - | - | |
| Quick Ratio | 4.75 | 4.75 | 5.02 | 2.16 | 11.00 | 4.65 | |
| Current Ratio | 4.84 | 4.84 | 5.58 | 2.53 | 11.10 | 4.67 | |
| Return on Equity (ROE) | -146.81% | -146.81% | -136.88% | -88.19% | -43.83% | -121.13% | |
| Return on Assets (ROA) | -40.68% | -40.68% | -51.51% | -43.15% | -22.00% | -29.61% | |
| Return on Capital Employed (ROCE) | -68.20% | -68.20% | -78.00% | -139.20% | -34.90% | -34.60% | |
| Earnings Yield | -27.64% | -32.74% | -52.58% | -24.25% | -7.57% | - | |
| FCF Yield | -22.96% | -27.20% | -34.94% | -21.31% | -9.19% | - | |
| Buyback Yield / Dilution | -25.43% | -25.43% | -30.37% | -168.41% | -161.23% | -391.47% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.